QNRX vs SHPH โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
SHPH Captures Institutional Edge (2โ1 Pillars ยท 3โ2 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Shuttle Pharmaceuticals Holdings, Inc. Common Stock (SHPH) driven by superior Growth & Margin, Momentum & Technical while QNRX counters with relative strength in Valuation. Fundamentally, QNRX trades at N/M Forward P/E with 0.0% operating margin (+0.0% YoY revenue) versus SHPH at N/M Forward P/E and 0.0% operating margin (+0.0% YoY). In options structure, QNRX sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against SHPH sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | QNRX | SHPH | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $16.1M | $17.6M | Larger Scale | Tie |
| Trailing P/E Ratio Valuation | 7.6x | N/M | Lower Multiple | QNRX |
| Forward P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Revenue Growth (YoY) Growth | +0.0% | +0.0% | Higher Growth | Tie |
| Operating Margin (TTM) Profitability | 0.0% | 0.0% | Higher Margin | Tie |
| Net Profit Margin Profitability | 0.0% | 0.0% | Higher Margin | Tie |
| Return on Equity (ROE) Capital Efficiency | -142.6% | -90.0% | Higher ROE | SHPH |
| 52-Week Range Position Momentum | 0% ($3โ$24) | 54% ($0โ$6) | Stronger Trend | SHPH |
| Beta / 30D Volatility Risk Regime | 1.34ฮฒ ยท 74% Vol | 9.23ฮฒ ยท 88% Vol | Lower Realized Risk | QNRX |
| Unified Institutional Score Composite Signal | 46.1 / 100 (HOLD) | 48.3 / 100 (HOLD) | Higher Composite | SHPH |